Stock Events

Stock Events

Search...

ARK Genomic Revolution

$24.24

1015

-$0.76-3.04% Friday 20:00

Statistics

Day High

25.18

Day Low

23.91

52W High

34.37

52W Low

21.97

Volume

2,384,833

Avg. Volume

2,371,396

Mkt Cap

-

P/E Ratio

-

Dividend Yield

-

Dividend

-

Dividends

0%Dividend Yield

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

N/A

1Y Growth

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ARKG. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Global X Genomics & Biotechnology

Global X Genomics & Biotechnology ETF, focuses on companies in genomics, making it a direct competitor to ARKG's thematic investment in genomics and biotech.

iShares Genomics Immunology and Healthcare

iShares Genomics Immunology and Healthcare ETF, targets similar genomics and immunology sectors, directly competing with ARKG's investment focus.

Invesco Biotechnology & Genome

Invesco Dynamic Biotechnology & Genome ETF, focuses on biotech and genomic companies, making it a competitor by targeting similar investment themes.

VanEck Vectors Biotech ETF, while broader in biotech, it includes genomic companies, positioning it as a competitor to ARKG.

SPDR S&P Biotech ETF, offers broad exposure to biotech, including genomics, competing with ARKG on the thematic investment front.

iShares Biotechnology

iShares Nasdaq Biotechnology ETF, a broad biotech ETF that includes genomic companies, making it a competitor in the space.

First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund, although broader, it competes by investing in some of the same genomic and biotech companies as ARKG.

ALPS Medical Breakthroughs

ALPS Medical Breakthroughs ETF, focuses on medical breakthroughs, including genomics, positioning it as a thematic competitor.

Virtus LifeSci Biotech Clinical Trials

Virtus LifeSci Biotech Clinical Trials ETF, focuses on biotech companies in clinical trials, including genomics, making it a niche competitor.

About

Miscellaneous

Investment Trusts/Mutual Funds

The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.

Show more...

CEO

Country

US

ISIN

US00214Q3020

Listings